Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof

Details for Australian Patent Application No. 2007354976 (hide)

International Classifications

Event Publications

7 January 2010 PCT application entered the National Phase

PCT publication WO2008/153237 Priority application(s): WO2008/153237

4 November 2010 Assignment before Grant

Korea Research Institute of Bioscience and Biotechnology The application has been assigned to Korea Research Institute of Bioscience and Biotechnology; PharmAbcine Inc. 2008

16 August 2012 Section 223 Application Allowed

Korea Research Institute of Bioscience and Biotechnology; PharmAbcine Inc. The time in which to request examination has been extended to 22 Jul 2012 . Address for service in Australia - Pizzeys Patent and Trade Mark Attorneys Level 20 324 Queen Street Brisbane QLD 4000 2009

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.